Medication info
DuoM 80/5 mg Tablet

DuoM 80/5 mg Tablet

Prescription medication경구
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
맥널티제약(주)
Appearance
Biconvex oval double tablet in white and light blue
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201904301 · Approved 2019.06.21 · Insurance code 641502810

Summary

Main use
Improving blood pressure in primary hypertension that is not controlled by monotherapy with telmisartan or amlodipine.
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with mild to moderate renal impairment, dose adjustment is not needed; however, for those with severe impairment, treatment should start at a lower dose and be gradually increased. In patients with liver impairment, the daily dose of telmisartan should not exceed 40 mg. Elderly patients may require a lower dose.
Child dose
The safety and efficacy of this medication in pediatric patients under 18 years have not been established, therefore its use is not recommended.

Ingredients

Manufacturer
맥널티제약(주)

Efficacy & effects

Improving blood pressure in primary hypertension that is not controlled by monotherapy with telmisartan or amlodipine.

  • Essential hypertension
View approved original text

This drug is used in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using telmisartan or amlodipine. In such cases, this medication helps to control blood pressure more effectively. Maintaining consistent blood pressure control is crucial for preventing cardiovascular complications, thus improving the patient's health.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with mild to moderate renal impairment, dose adjustment is not needed; however, for those with severe impairment, treatment should start at a lower dose and be gradually increased. In patients with liver impairment, the daily dose of telmisartan should not exceed 40 mg. Elderly patients may require a lower dose.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years have not been established, therefore its use is not recommended.

Precautions

This medication can cause serious harm to the fetus in pregnant women, particularly in the second and third trimesters, so pregnant women or those who may become pregnant should not take it. This medication should not be administered to individuals with allergies to the active ingredients or related components, nursing mothers, those with severe liver impairment or certain heart conditions, or individuals with hypotension or in shock. Patients with primary aldosteronism or certain heart valve diseases should use this medication cautiously, and those with impaired liver function should also take extra care. Patients with gastrointestinal disorders may experience issues such as gastrointestinal bleeding when taking this medication, so caution is advised. Patients with reduced kidney function, dialysis patients, and the elderly also require special caution when using this medication. Side effects such as dizziness and peripheral edema are common, and fainting or heart-related issues may occur rarely; thus, if any unusual symptoms appear, patients should consult medical personnel immediately. Symptoms of hypotension can manifest if blood pressure drops too low, particularly in patients who are deficient in fluid or salt, so their condition should be checked before taking the medication, and they must follow the doctor's instructions. During the treatment with this medication, potassium levels may rise; thus, caution is warranted if taken with potassium supplements or medications containing potassium, and regular blood tests are recommended. Patients at risk for myocardial infarction or angina should be cautious, as symptoms may worsen with the use of this medication. This medication may induce drowsiness or dizziness, so caution is advised when driving or operating hazardous machinery. There may be interactions with other medications, thus patients should consult medical personnel, especially if taking digoxin, lithium, warfarin, or non-steroidal anti-inflammatory drugs. This medication should not be taken during pregnancy, and if pregnancy is confirmed, it must be stopped immediately, and alternative treatments should be sought. It is also safer for nursing mothers to avoid this medication. The safety and efficacy of this medication in children or adolescents under 18 years have not been sufficiently established, and therefore its use is not recommended. In case of overdose, symptoms such as hypotension, heart rate changes, and dizziness may occur, requiring immediate medical attention for appropriate treatment. This medication must be kept out of reach of children and stored sealed until just before administration to maintain its quality.

Side effects and when to seek care immediately

Serious side effects

Hypersensitivity, anaphylactic reactions, sepsis, leukopenia, thrombocytopenia, syncope, myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, dyspnea, liver dysfunction, liver impairment, hepatitis, jaundice, angioedema (with fatal outcomes), toxic skin rash, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, renal dysfunction (including acute renal failure), vasculitis, intestinal vascular swelling, congestive heart failure, cerebral infarction, hepatocellular carcinoma

Mild side effects

  • Dizziness
  • peripheral edema
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • anemia
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
Show 27 more
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • migraine
  • headache
  • sensory abnormalities
  • peripheral neuropathy
  • visual disturbances
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • rhinitis
  • changes in bowel habits
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container that shields it from light, and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Biconvex oval double tablet in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.